Menu
Menu
Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n
<\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n
Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n
<\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Franklin County officials are acting proactively as US President Donald Trump<\/a>'s administration continues to implement rapid-fire policy changes. The Franklin County Board of Commissioners has, for the first time, enlisted a Washington lobbying company to represent the county before federal agencies and Congress. Additionally, the business will assist county officials in staying up to date with the rapidly evolving federal situation.<\/p>\n\n\n\n The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
<\/p>\n","post_title":"Powerful lobbyists rush to block landmark New York debt reform bill","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"powerful-lobbyists-rush-to-block-landmark-new-york-debt-reform-bill","to_ping":"","pinged":"","post_modified":"2025-06-14 19:12:22","post_modified_gmt":"2025-06-14 19:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7976","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7963,"post_author":"7","post_date":"2025-06-12 18:23:39","post_date_gmt":"2025-06-12 18:23:39","post_content":"\n Franklin County officials are acting proactively as US President Donald Trump<\/a>'s administration continues to implement rapid-fire policy changes. The Franklin County Board of Commissioners has, for the first time, enlisted a Washington lobbying company to represent the county before federal agencies and Congress. Additionally, the business will assist county officials in staying up to date with the rapidly evolving federal situation.<\/p>\n\n\n\n The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Similar claims were made in a document distributed by the Securities Industry and Financial Markets Association, or SIFMA, on June 4. Two Republican senators, Jack Martins and Mark Walczyk, delivered lengthy speeches against the law during floor discussions prior to the Senate passing the bill. SIFMA's 2024 statement on the measure was read by Walczyk.<\/p>\n\n\n\n <\/p>\n","post_title":"Powerful lobbyists rush to block landmark New York debt reform bill","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"powerful-lobbyists-rush-to-block-landmark-new-york-debt-reform-bill","to_ping":"","pinged":"","post_modified":"2025-06-14 19:12:22","post_modified_gmt":"2025-06-14 19:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7976","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7963,"post_author":"7","post_date":"2025-06-12 18:23:39","post_date_gmt":"2025-06-12 18:23:39","post_content":"\n Franklin County officials are acting proactively as US President Donald Trump<\/a>'s administration continues to implement rapid-fire policy changes. The Franklin County Board of Commissioners has, for the first time, enlisted a Washington lobbying company to represent the county before federal agencies and Congress. Additionally, the business will assist county officials in staying up to date with the rapidly evolving federal situation.<\/p>\n\n\n\n The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
the groups said, warning that if New York enacted the law, sovereign debt issuance, trading, and litigation may go to other states.<\/p>\n\n\n\n Similar claims were made in a document distributed by the Securities Industry and Financial Markets Association, or SIFMA, on June 4. Two Republican senators, Jack Martins and Mark Walczyk, delivered lengthy speeches against the law during floor discussions prior to the Senate passing the bill. SIFMA's 2024 statement on the measure was read by Walczyk.<\/p>\n\n\n\n <\/p>\n","post_title":"Powerful lobbyists rush to block landmark New York debt reform bill","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"powerful-lobbyists-rush-to-block-landmark-new-york-debt-reform-bill","to_ping":"","pinged":"","post_modified":"2025-06-14 19:12:22","post_modified_gmt":"2025-06-14 19:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7976","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7963,"post_author":"7","post_date":"2025-06-12 18:23:39","post_date_gmt":"2025-06-12 18:23:39","post_content":"\n Franklin County officials are acting proactively as US President Donald Trump<\/a>'s administration continues to implement rapid-fire policy changes. The Franklin County Board of Commissioners has, for the first time, enlisted a Washington lobbying company to represent the county before federal agencies and Congress. Additionally, the business will assist county officials in staying up to date with the rapidly evolving federal situation.<\/p>\n\n\n\n The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\"This business is lucrative and other states know it,\" <\/p>\n<\/blockquote>\n\n\n\n the groups said, warning that if New York enacted the law, sovereign debt issuance, trading, and litigation may go to other states.<\/p>\n\n\n\n Similar claims were made in a document distributed by the Securities Industry and Financial Markets Association, or SIFMA, on June 4. Two Republican senators, Jack Martins and Mark Walczyk, delivered lengthy speeches against the law during floor discussions prior to the Senate passing the bill. SIFMA's 2024 statement on the measure was read by Walczyk.<\/p>\n\n\n\n <\/p>\n","post_title":"Powerful lobbyists rush to block landmark New York debt reform bill","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"powerful-lobbyists-rush-to-block-landmark-new-york-debt-reform-bill","to_ping":"","pinged":"","post_modified":"2025-06-14 19:12:22","post_modified_gmt":"2025-06-14 19:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7976","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7963,"post_author":"7","post_date":"2025-06-12 18:23:39","post_date_gmt":"2025-06-12 18:23:39","post_content":"\n Franklin County officials are acting proactively as US President Donald Trump<\/a>'s administration continues to implement rapid-fire policy changes. The Franklin County Board of Commissioners has, for the first time, enlisted a Washington lobbying company to represent the county before federal agencies and Congress. Additionally, the business will assist county officials in staying up to date with the rapidly evolving federal situation.<\/p>\n\n\n\n The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\"This business is lucrative and other states know it,\" <\/p>\n<\/blockquote>\n\n\n\n the groups said, warning that if New York enacted the law, sovereign debt issuance, trading, and litigation may go to other states.<\/p>\n\n\n\n Similar claims were made in a document distributed by the Securities Industry and Financial Markets Association, or SIFMA, on June 4. Two Republican senators, Jack Martins and Mark Walczyk, delivered lengthy speeches against the law during floor discussions prior to the Senate passing the bill. SIFMA's 2024 statement on the measure was read by Walczyk.<\/p>\n\n\n\n <\/p>\n","post_title":"Powerful lobbyists rush to block landmark New York debt reform bill","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"powerful-lobbyists-rush-to-block-landmark-new-york-debt-reform-bill","to_ping":"","pinged":"","post_modified":"2025-06-14 19:12:22","post_modified_gmt":"2025-06-14 19:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7976","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7963,"post_author":"7","post_date":"2025-06-12 18:23:39","post_date_gmt":"2025-06-12 18:23:39","post_content":"\n Franklin County officials are acting proactively as US President Donald Trump<\/a>'s administration continues to implement rapid-fire policy changes. The Franklin County Board of Commissioners has, for the first time, enlisted a Washington lobbying company to represent the county before federal agencies and Congress. Additionally, the business will assist county officials in staying up to date with the rapidly evolving federal situation.<\/p>\n\n\n\n The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n Franklin County already has a two-person Government Affairs office run by the Board of Commissioners that represents the county in lobbying the Ohio General Assembly and federal representatives.<\/p>\n","post_title":"Trump cuts push Franklin County to get help from D.C. lobbyists","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"trump-cuts-push-franklin-county-to-get-help-from-d-c-lobbyists","to_ping":"","pinged":"","post_modified":"2025-06-12 18:23:39","post_modified_gmt":"2025-06-12 18:23:39","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7963","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7970,"post_author":"7","post_date":"2025-06-11 18:42:27","post_date_gmt":"2025-06-11 18:42:27","post_content":"\n Leading artificial intelligence firms are quickly increasing their lobbying presence in Washington<\/a>, which is now proving to be a relatively easy target. Two privately held AI companies, OpenAI and Anthropic, have increased their hiring in Washington, stepped up their lobbying efforts, and are competing for contracts from the estimated $75 billion federal IT budget, much of which is now devoted to AI. Previously, they had positioned themselves as cautious, research-based alternatives to aggressive Big Tech companies.<\/p>\n\n\n\n This lobbying effort seeks to leverage a surge of backing from the Republican Congress and the Trump administration, which have energized the AI sector as a key component of American competitiveness and a way to reduce the size of the government workforce.<\/p>\n\n\n\n Although they don't all put up a united front, the AI lobby is so far largely succeeding in its goals. <\/p>\n\n\n\n As part of its mega bill that is presently pending in the Senate, the House imposed a ten-year moratorium on state and municipal AI regulation, demonstrating politicians' deference to industry.<\/p>\n\n\n\n However, detractors fear that the AI debate in Washington has devolved into an unduly intimate circle between businesses and their Republican backers, obscuring significant worries about the development of a potent but challenging technology.<\/p>\n\n\n\n The AI lobby wants more government contracts and fewer rules that restrict its expansion. This is a typical Washington twofer. The government's AI funding has been increasing. Building AI capability is a goal shared by all federal departments, including the Department of Defense, the Department of Energy, the IRS, and the Department of Veterans Affairs. It is anticipated that the push for automation and workforce reductions by the Trump government would increase the need for private companies to use AI to bridge the gap.<\/p>\n\n\n\n Growth in AI necessitates energy, and AI businesses have played <\/a>a significant role in the current campaign in the White House and Congress to ease permits for the building of the latest data centres, tapping into new energy sources, and drawing private acquisitions for these undertakings.<\/p>\n\n\n\n In an infrastructure strategy published late last year, OpenAI urged the federal government to get ready for a huge increase in demand for energy supplies and computing capacity in the United States. Its ideas include extending the national power system, increasing government support for private investment in large energy projects, and establishing special AI zones to expedite licenses for energy and data centres.<\/p>\n\n\n\n Now, members of the Trump administration are echoing those ideas very precisely. Trump's AI and crypto czar, David Sacks, presented a broad vision at the Bitcoin 2025 Conference in Las Vegas last month that reflected the lobbying objectives of the AI sector.<\/p>\n","post_title":"AI industry establishes strong lobbying presence in Washington","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"ai-industry-establishes-strong-lobbying-presence-in-washington","to_ping":"","pinged":"","post_modified":"2025-06-12 18:45:01","post_modified_gmt":"2025-06-12 18:45:01","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7970","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7952,"post_author":"7","post_date":"2025-06-10 13:29:20","post_date_gmt":"2025-06-10 13:29:20","post_content":"\n Nonprofit OpenSecrets has reported that medtech companies, which employ tens of thousands of Minnesotans, have boosted their financial contributions to lobbying <\/a>efforts in Washington, D.C. by over $600,000 in the first quarter of this year, as uncertainty in the city's business landscape grows.<\/p>\n\n\n\n Boston Scientific, Abbott Laboratories, and Medtronic all acknowledged pushing for long-supported causes, including taxes and Medicare eligibility. However, documents also show that the Trump administration's goals have changed, moving from increasing tariffs with foreign nations to reducing the size of the federal workforce.<\/p>\n\n\n\n Boston Scientific, which has a sizable cardiology subsidiary located in Minnesota, increased its spending by around 20% during the first three months of 2025, reporting $572,000 in federal lobbying.<\/p>\n\n\n\n Files show that company representatives lobbied Congress on supply chain issues, promoting issues like the House Select Committee's decisions on strategic competition between the United States and the Chinese Communist Party that could impact the medical device supply chain.<\/p>\n\n\n\n In the first quarter of 2024, Medtronic, a Fridley-based company, boosted its federal lobbying spending by 10% to $1.07 million. They discussed topics including artificial intelligence, supply chains, tariffs, and the \"FDA workforce.\"<\/p>\n\n\n\n Some businesses in D.C. have begun collaborating with MedTech and AdvaMed enterprises. Disclosures show that AdvaMed and Boston Scientific paid the law firm Alston & Bird $30,000<\/a> and $80,000, respectively, for services spanning from commerce to artificial intelligence.<\/p>\n\n\n\n A consultant from Tarplin, Downs & Young in Washington, D.C., was hired by Abbott and AdvaMed. The topics of national trade and Medicare reimbursement kept coming up in TDY's advocacy for Abbott.<\/p>\n\n\n\n Mehlman Consulting, a Washington, D.C.-based firm that is only a few blocks from the White House, states in a first-quarter filing that it has done around $60,000 for Medtronic and has spoke out on issues concerning the taxation of multinational corporations and U.S. trade policy. Figures are rounded to the nearest $10,000 for disclosure purposes forms.<\/p>\n\n\n\n <\/p>\n","post_title":"Medtech giants boost DC lobbying amid policy shifts","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"medtech-giants-boost-dc-lobbying-amid-policy-shifts","to_ping":"","pinged":"","post_modified":"2025-06-10 13:29:20","post_modified_gmt":"2025-06-10 13:29:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7952","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":42},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
According to a June 4 document from the Loan Syndications and Trading Association and Creditor Rights Coalition, traders, legal firms, and financial institutions likely earned \"substantial revenue\" in 2024 from the trading of more than $700 billion in sovereign bonds subject to New York law.<\/p>\n\n\n\n \"This business is lucrative and other states know it,\" <\/p>\n<\/blockquote>\n\n\n\n the groups said, warning that if New York enacted the law, sovereign debt issuance, trading, and litigation may go to other states.<\/p>\n\n\n\n Similar claims were made in a document distributed by the Securities Industry and Financial Markets Association, or SIFMA, on June 4. Two Republican senators, Jack Martins and Mark Walczyk, delivered lengthy speeches against the law during floor discussions prior to the Senate passing the bill. SIFMA's 2024 statement on the measure was read by Walczyk.<\/p>\n\n\n\n <\/p>\n","post_title":"Powerful lobbyists rush to block landmark New York debt reform bill","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"powerful-lobbyists-rush-to-block-landmark-new-york-debt-reform-bill","to_ping":"","pinged":"","post_modified":"2025-06-14 19:12:22","post_modified_gmt":"2025-06-14 19:12:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7976","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7963,"post_author":"7","post_date":"2025-06-12 18:23:39","post_date_gmt":"2025-06-12 18:23:39","post_content":"\n Franklin County officials are acting proactively as US President Donald Trump<\/a>'s administration continues to implement rapid-fire policy changes. The Franklin County Board of Commissioners has, for the first time, enlisted a Washington lobbying company to represent the county before federal agencies and Congress. Additionally, the business will assist county officials in staying up to date with the rapidly evolving federal situation.<\/p>\n\n\n\n The Trump administration initiated a large-scale review and cutback of federal government consulting contracts, targeting over 20,000 contracts for \"non-essential\" services, resulting in cancellations worth billions of dollars. This initiative has caused significant disruption in the Washington D.C. area contracting industry, including layoffs and contract renegotiations aimed at reducing costs and improving productivity.<\/p>\n\n\n\n Consulting firms and contractors affected by these cuts have been actively lobbying <\/a>federal agencies, including the General Services Administration (GSA), to avoid contract terminations or to negotiate exemptions.<\/p>\n\n\n\n The commissioners are worried about anticipated federal changes that might hurt citizens, including cuts to Medicaid, Supplemental Nutrition Assistance Program (SNAP), and Head Start, Franklin County Commissioner Erica C. Crawley said. Crawley has referred to Head Start, which provides low-income families with childcare funding, as a lifeline.<\/p>\n\n\n\n According to Crawley, since so many federal awards have been reduced or are currently in uncertainty, the commissioners also wish to promote county programs that get federal funding.<\/p>\n\n\n\n For a year's worth of lobbying and consulting work, the county will pay Batie and Associates $96,000. At their June 10 meeting, the three Democratic commissioners unanimously authorized the deal.<\/p>\n\n\n\n \"These are unprecedented times, and we believe it's crucial for us to meet with our federal representatives, get a handle on what's happening at the agency level, strengthen those relationships, and let our representatives know what matters most to us residents,\" Crawley said.<\/p>\n\n\n\n This action strengthens the county's current connections and lobbying efforts. In response to the Centers for Disease Control and Prevention cutting $250<\/a> million in funds via the Ohio Department of Health, which affected local agencies like Franklin County's, Crawley said she visited with Sen. Bernie Moreno's office.<\/p>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
\n
Why are AI firms rapidly increasing Washington lobbying efforts?<\/h2>\n\n\n\n
What role do federal contracts play in AI expansion?<\/h2>\n\n\n\n
How are lobbying firms like TDY influencing medtech policy?<\/h2>\n\n\n\n
\n
\n